Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 133

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 133
---
ies with the generally applicable policies,
practices and procedures of the Company for submission of expense reports, receipts or similar documentation of such expenses. Any reimbursements
for allocated expenses (as compared to out-of-pocket expenses of the director in excess of $500) must be approved in advance by the Company.

Other
than as set forth in the table below and as described more fully below, we did not pay any compensation or make any equity awards or
non-equity awards to any of our non-employee directors during 2024. Directors may be reimbursed for travel and other expenses directly
related to their activities as directors. Directors who also serve as employees receive no additional compensation for their service
as directors. During 2024, each of Christer Rosén, our Chief Executive Officer, Marshall Hayward, our Chief Scientific Officer,
and Alison Silva, our President and Chief Business Officer, was a member of our board of directors, as well as an employee, and therefore,
received no additional compensation for their services as a director. See “—2024 Summary Compensation Table” for more
information about compensation to our NEOs for 2024 and 2023. The following table presents the total compensation for each person who
served as a non-employee director during 2024.

2024
Director Compensation Table 

    Name 
    Year  
    Fees Earned or Paid in Cash ($)  
    Stock Awards ($)  
    Option Awards ($)  
    Total ($) 
  
    Nicholas H. Hemmerly 
    2024  
    $49,000  
    $0  
    $0  
    $49,000 

    Julie Kampf 
    2024  
    $42,500  
    $0  
    $0  
    $42,500 

    Holger Weis 
    2024  
    $44,000  
    $0  
    $0  
    $44,000 

    Alison W. Brady 
    2024  
    $40,000  
    $0  
    $0  
    $40,000 

Director
Agreements

On
September 8, 2021, the Company entered into Independent Director Agreements with each of Allison Brady, Holger Weis, Julie Kampf and
Nick Hemmerly (each, a “Director”) relating to their service as independent directors of the Company.

114